Theriva Biologics, Inc. (TOVX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 300K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 24K | 0 | 0 | 0 | 0 | 27K | 0 | 0 | 39K | 39K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 8% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 276K | 0 | 0 | 0 | 0 | -27K | 0 | 0 | -39K | -39K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | 92% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 100% | - | - | 100% | 30.77% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 2.38M | 2.06M | 4.44M | 13.13M | 4.42M | 4.37M | 7.89M | 8.49M | 5.35M | 5.84M | 4.22M | 5.82M | 5.18M | 7.32M | 4.99M | 5.03M | 4.25M | 5.26M | 3.27M | 3.2M |
| OpEx % of Revenue | 792% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 2.07M | 931K | 1.89M | 11.18M | 1.43M | 1.48M | 2.3M | 1.47M | 1.89M | 1.64M | 1.81M | 2.25M | 2.2M | 2.15M | 2.42M | 1.54M | 1.66M | 2.49M | 1.3M | 1.26M |
| SG&A % of Revenue | 690.67% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 355K | 1.13M | 2.55M | 1.95M | 2.97M | 2.89M | 2.73M | 2.95M | 3.46M | 4.2M | 4.01M | 3.13M | 2.98M | 3.07M | 2.57M | 3.48M | 2.6M | 2.78M | 1.97M | 1.93M |
| R&D % of Revenue | 118.33% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -51K | 0 | 0 | 0 | 21K | 0 | 1000K | 1000K | 0 | 0 | -1000K | 432K | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.1M | -2.06M | -4.44M | -13.13M | -4.42M | -4.39M | -7.89M | -8.49M | -5.39M | -5.88M | -4.22M | -5.82M | -5.18M | -7.32M | -4.99M | -5.03M | -4.25M | -5.26M | -3.27M | -3.2M |
| Operating Margin % | -700% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 52.46% | 53.06% | 43.7% | -54.71% | 18.08% | 25.23% | -86.98% | -45.84% | -4.13% | 19.67% | 15.4% | -15.8% | -21.78% | -38.97% | -52.24% | -57.21% | -67.6% | -146.95% | -55.14% | -10.66% |
| EBITDA | -2.08M | -2.04M | -4.41M | -13.11M | -4.39M | -4.37M | -7.85M | -8.45M | -5.35M | -5.84M | -4.19M | -5.79M | -5.15M | -7.29M | -4.96M | -5.01M | -4.23M | -5.25M | -3.26M | -3.17M |
| EBITDA Margin % | -692% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 52.72% | 53.39% | 43.82% | -55.09% | 17.97% | 25.19% | -87.63% | -45.99% | -4.02% | 19.93% | 15.64% | -15.58% | -21.54% | -38.84% | -52.35% | -57.78% | -69.09% | -150.1% | -58.26% | -12.12% |
| D&A (Non-Cash Add-back) | 24K | 27K | 28K | 27K | 26K | 27K | 33K | 38K | 39K | 39K | 32K | 32K | 32K | 25K | 24K | 18K | 18K | 13K | 18K | 23K |
| EBIT | -2.1M | -2.06M | -4.36M | -13.13M | -4.4M | -4.45M | -5.04M | -4.42M | -5.39M | -5.91M | -5.82M | -5.39M | -5.18M | -5.23M | -4.99M | -5.03M | -4.25M | -5.26M | -3.27M | -3.2M |
| Net Interest Income | 82K | 72K | 65K | 54K | 96K | 138K | 158K | 173K | 228K | 312K | 382K | 381K | 364K | 315K | 170K | 26K | 2K | 2K | 2K | 2K |
| Interest Income | 82K | 72K | 65K | 54K | 96K | 138K | 158K | 173K | 228K | 312K | 382K | 381K | 364K | 315K | 170K | 26K | 2K | 2K | 2K | 2K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 56K | 67K | 79K | 74K | 93K | -52K | 161K | 172K | 227K | -31K | 388K | 377K | 370K | 314K | 161K | 17K | -21K | 2K | 2K | 2K |
| Pretax Income | -2.04M | -2M | -4.36M | -13.06M | -4.32M | -4.45M | -7.73M | -8.32M | -5.17M | -5.91M | -3.83M | -5.44M | -4.81M | -7M | -4.83M | -5.01M | -4.27M | -5.26M | -3.27M | -3.19M |
| Pretax Margin % | -681.33% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -424K | -527K | -359K | -330K | -558K | -335K | -532K | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 7.18% | 13.76% | 6.6% | 6.86% | 7.97% | 6.94% | 10.62% | 0% | 0% | 0% | 0% |
| Net Income | -2.04M | -2M | -4.36M | -13.06M | -4.32M | -4.45M | -7.73M | -8.32M | -5.17M | -5.49M | -3.3M | -5.08M | -4.48M | -6.45M | -4.49M | -4.48M | -4.27M | -5.26M | -3.27M | -3.19M |
| Net Margin % | -681.33% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 52.73% | 55.12% | 43.55% | -57.02% | 16.28% | 18.92% | -133.91% | -63.57% | -15.34% | 14.9% | 26.44% | -13.56% | -4.8% | -22.46% | -37.18% | -40.13% | -68.49% | -149.55% | -55.63% | -11.44% |
| Net Income (Continuing) | -2.04M | -2M | -4.36M | -13.06M | -4.32M | -4.45M | -7.73M | -8.32M | -5.17M | -5.49M | -3.3M | -5.08M | -4.48M | -6.45M | -4.49M | -4.48M | -4.27M | -5.26M | -3.27M | -3.19M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.77M | -2.77M |
| EPS (Diluted) | -0.05 | -0.10 | -0.45 | -1.93 | -1.55 | -1.60 | -6.81 | -10.72 | -7.53 | -8.00 | -4.85 | -8.38 | -7.40 | -8.89 | -0.30 | -0.31 | -0.31 | -0.40 | -0.25 | -0.24 |
| EPS Growth % | 96.77% | 93.86% | 93.39% | 82% | 79.42% | 80% | -40.41% | -27.92% | -1.76% | 10.01% | -1516.67% | -2603.23% | -2287.1% | -2122.5% | -20% | -29.17% | -10.71% | 60% | 76.85% | 84.62% |
| EPS (Basic) | -0.05 | -0.10 | -0.45 | -1.93 | -1.55 | -4.26 | -6.81 | -10.75 | -7.53 | -8.00 | -4.85 | -8.38 | -7.40 | -8.89 | -0.30 | -0.31 | -0.31 | -0.40 | -0.25 | -0.24 |
| Diluted Shares Outstanding | 41.07M | 12.14M | 9.68M | 6.75M | 2.78M | 1.35M | 1.13M | 775.74K | 685.9K | 685.92K | 681.71K | 606.65K | 604.96K | 629.19K | 15.84M | 15.84M | 13.82M | 13.2M | 13.2M | 13.2M |
| Basic Shares Outstanding | 41.07M | 12.14M | 9.68M | 6.75M | 2.78M | 1.35M | 1.13M | 775K | 685.9K | 685.92K | 681.71K | 606.65K | 604.96K | 629.19K | 15.84M | 15.84M | 13.82M | 13.2M | 13.2M | 13.2M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |